prikaz prve stranice dokumenta Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time
  Download
PDF 459.29 KB
Scientific paper - Review paper
Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time
Medicina, 57 (2021); 1057. https://doi.org/10.3390/medicina57101057
Vranić, Luka; Radovan, Anja; Poropat, Goran; Mikolašević, Ivana; Milić, Sandra

Linked objects
COVID-19 (zbirka 2.) | Virtual collection
Cite this document

Vranić, L., Radovan, A., Poropat, G., Mikolašević, I. & Milić, S. (2021). Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time. Medicina, 57.. doi: 10.3390/medicina57101057

Vranić, Luka, et al. "Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time." Medicina, vol. 57, 2021. https://doi.org/10.3390/medicina57101057

Vranić, Luka, Anja Radovan, Goran Poropat, Ivana Mikolašević and Sandra Milić. "Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time." Medicina 57 (2021). https://doi.org/10.3390/medicina57101057

Vranić, L., et al. (2021) 'Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time', Medicina, 57. doi: 10.3390/medicina57101057

Vranić L, Radovan A, Poropat G, Mikolašević I, Milić S. Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time. Medicina [Internet]. 2021 October 03 [cited 2024 October 22];57. doi: 10.3390/medicina57101057

L. Vranić, A. Radovan, G. Poropat, I. Mikolašević and S. Milić, "Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time", Medicina, vol. 57, October 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:392482. [Accessed: 22 October 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time
AuthorLuka Vranić
AuthorAnja Radovan
AuthorGoran Poropat
AuthorIvana Mikolašević
AuthorSandra Milić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Infectology
Abstract (english)
The COVID-19 pandemic was and still is a global burden with more than 178,000,000 cases reported so far. Although it mainly affects respiratory organs, COVID-19 has many extrapulmonary manifestations, including, among other things, liver injury. Many hypotheses have been proposed to explain direct and indirect impacts of the SARS-CoV-2 virus on the liver. Studies have shown that around 15–30% of patients with COVID-19 have underlying liver disease, and 20–35% of patients with COVID-19 had altered liver enzymes at admission. One of the hypotheses is reactivation of an underlying liver disease, such as non-alcoholic fatty liver disease (NAFLD). Some studies have shown that NAFLD is associated with severe COVID-19 and poor outcome; nevertheless, other studies showed no significant difference between groups in comparing complications and clinical outcomes. Patients with NAFLD may suffer severe COVID-19 due to other comorbidities, especially cardiovascular diseases. The link between NAFLD and COVID-19 is not clear yet, and further studies and research are needed.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleMedicina
Numberingvol. 57, 1057
e-ISSN1648-9144
DOIhttps://doi.org/10.3390/medicina57101057
URN:NBNurn:nbn:hr:184:392482
Publication2021-10-03
Document URLhttps://www.mdpi.com/1648-9144/57/10/1057
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2022-09-20 11:14:33